EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Behavioral and genetic analysis of the effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) in C. elegans

Amanda M White, Adele D Bauer iD, Serge Faumont iD, Shawn R Lockery iD

PLOS One · 26.08.2025 · 20 (8) · e0329538

DOI: 10.1371/journal.pone.0329538 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 26.08.2025. Verfasst von Amanda M White und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neuroscience, University of Oregon, Eugene, Oregon, United States of America. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Hallucinogens, Amphetamines, Behavior, Animal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIDA NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychedelics show promise in treating depression, PTSD, and substance use disorder, prompting research into their mechanisms of action. Most studies use rodent models, but genetic tools can be challenging to apply in this approach. Invertebrate models, like C. elegans , offer a cost-effective alternative with short generation times and genetic tractability. This study examined the worm’s response to the psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) by assessing four serotonergic behaviors. Effects of DOI exposure on locomotion speed, swimming frequency, and egg-laying were undetectable, but DOI strongly inhibited feeding. Interestingly, this effect was independent of serotonin receptors, suggesting DOI may act through alternative pathways. These findings indicate that C. elegans can serve as a useful model for studying psychedelic drug effects, potentially revealing novel mechanisms beyond the serotonergic system. Further research could help clarify these pathways, improving our understanding of the therapeutic potential of psychedelics and refining their efficacy in treating neuropsychiatric disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caenorhabditis elegansHallucinogensAmphetaminesBehavior, AnimalAnimalsLocomotionReceptors, SerotoninSerotonin

Substanzen

HallucinogensAmphetamines4-iodo-2,5-dimethoxyphenylisopropylamineReceptors, SerotoninSerotonin

Autor:innen und Institutionen

  • Institute of Neuroscience, University of Oregon, Eugene, Oregon, United States of America.

ORCID-Profile: Adele D Bauer, Serge Faumont, Shawn R Lockery

Förderung

  • NIH HHS
  • NIDA NIH HHS
  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

White, A. M., Bauer, A. D., Faumont, S., & Lockery, S. R. (2025). Behavioral and genetic analysis of the effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) in C. elegans. PLOS One, 20(8), e0329538. https://doi.org/10.1371/journal.pone.0329538

Vancouver

White AM, Bauer AD, Faumont S, Lockery SR. Behavioral and genetic analysis of the effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) in C. elegans. PLOS One. 2025;20(8):e0329538. doi:10.1371/journal.pone.0329538

BibTeX
@article{White2025,
  author = {White, Amanda M and Bauer, Adele D and Faumont, Serge and Lockery, Shawn R},
  title = {Behavioral and genetic analysis of the effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) in C. elegans},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {8},
  pages = {e0329538},
  doi = {10.1371/journal.pone.0329538}
}
Kostenlos starten →